Daniel A. Welch is VP at PHIBRO ANIMAL HEALTH CORP (PAHC). They have made 6 open-market trades across 1 company since 2014, most recently 2017-03-14.
CIK 0001069899
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PAHC | 1,900 | $75K |
Shares reported on the most recent Form 4, priced at the 2017-03-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PAHC | SELL | 2017-03-14 | 2017-03-16 | $27.22 | $136K | -0.4% | +0.4% | +25.1% |
| PAHC | SELL | 2017-02-27 | 2017-03-16 | $28.30 | $142K | -0.4% | +0.4% | +25.1% |
| PAHC | SELL | 2017-02-16 | 2017-02-16 | $29.55 | $148K | -4.2% | -6.4% | +14.1% |
| PAHC | SELL | 2016-01-26 | 2016-01-28 | $32.05 | $96K | +6.3% | -13.2% | -32.6% |
| PAHC | SELL | 2016-01-26 | 2016-01-28 | $32.05 | $96K | +6.3% | -13.2% | -32.6% |
| PAHC | SELL · 10b5-1 | 2015-10-16 | 2015-10-19 | $32.93 | $99K | -5.6% | -1.7% | -2.4% |
| PAHC | SELL · 10b5-1 | 2015-02-17 | 2015-02-19 | $31.90 | $128K | -5.6% | -1.7% | -1.7% |
| PAHC | SELL | 2014-12-19 | 2014-12-23 | $29.20 | $117K | -5.6% | -1.7% | -1.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.